Holmer M, Ingre M, Färkkilä M, Ponsioen C, Mol B, Schramm C, Folseraas T, Wiencke K, Cazzagon N, Catanzaro E, Molinaro A, Nilsson E, Vessby J, Kechagias S, Nyhlin N, Werner M, Bergquist A (2025)
Reply: Competing risk and surveillance thresholds for HCC in Patients with PSC
Hepatology (in press)
DOI 10.1097/HEP.0000000000001651, PubMed 41405465

Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, Calvisi DF, Cardenas A, Cardinale V, Carpino G, Coulouarn C, Dopazo C, Edeline J, Fabris L, Folseraas T, Forner A, Goeppert B, Heikenwalder M, Kendall TJ, Khan SA, Klümpen HJ, Koerkamp BG, Lamarca A, Lindsey S et al. (2025)
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Nat Rev Gastroenterol Hepatol (in press)
DOI 10.1038/s41575-025-01153-w, PubMed 41372578

Breder S, Villard C, Eide E, Wang B, Engesæter LK, Reims HM, Hov JR, Melum E, Aabakken L, Line PD, Lømo J, Grzyb K, Wiencke K, Bergquist A, Folseraas T (2025)
A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits
JHEP Rep, 7 (12), 101598
DOI 10.1016/j.jhepr.2025.101598, PubMed 41321929